Laura Serwer

Company: CRISPR Therapeutics

Job title: Senior Director, Head of Pharmacology and Toxicology

Bio:

Dr. Serwer leads the in vivo pharmacology and toxicology teams at CRISPR Therapeutics, and her team has lead nonclinical safety efforts for multiple INDs/CTAs for CRISPR-based therapeutics across oncology and metabolic indications. Prior to working at CRISPR Therapeutics, Dr. Serwer led toxicology programs for several IND-stage large molecule therapeutics.

Seminars:

Panel Discussion: Ensuring Product Safety When Moving Into the Clinic 10:00 am

Outlining a checklist of necessary steps for comprehensively demonstrating product safety Practical steps for validating the specificity of a CRISPR/Cas therapy Safety experiments, analysis, and presentation to regulators to transition into the clinic Key considerations for product safety profiling with different delivery approachesRead more

day: Day 1 AM